CAPEX Drug Patent Profile
✉ Email this page to a colleague
When do Capex patents expire, and what generic alternatives are available?
Capex is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in CAPEX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capex
A generic version of CAPEX was approved as fluocinolone acetonide by TARO on April 27th, 1982.
Summary for CAPEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 4,332 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CAPEX |
What excipients (inactive ingredients) are in CAPEX? | CAPEX excipients list |
DailyMed Link: | CAPEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CAPEX
US Patents and Regulatory Information for CAPEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | CAPEX | fluocinolone acetonide | SHAMPOO;TOPICAL | 020001-001 | Aug 27, 1990 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |